FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets
Status: Discontinuation
»Therapeutic Categories: Psychiatry

Expand all

Nesher Pharmaceuticals (USA) LLC (Revised 07/12/2021)

Company Contact Information:
877-993-8779

Presentation Posting Date Related Information
5 mg, 100 Count Bottle (NDC 68382-950-01) 07/12/2021 Availability and Estimated Shortage Duration (Discontinuance): January 2022
7.5 mg, 100 Count Bottle (NDC 68382-951-01) 07/12/2021 Availability and Estimated Shortage Duration (Discontinuance): January 2022
10 mg, 100 Count Bottle (NDC 68382-952-01) 07/12/2021 Availability and Estimated Shortage Duration (Discontinuance): January 2022
12.5 mg, 100 Count Bottle (NDC 68382-953-01) 07/12/2021 Availability and Estimated Shortage Duration (Discontinuance): January 2022
15 mg, 100 Count Bottle (NDC 68382-954-01) 07/12/2021 Availability and Estimated Shortage Duration (Discontinuance): January 2022
20 mg, 100 Count Bottle (NDC 68382-955-01) 07/12/2021 Availability and Estimated Shortage Duration (Discontinuance): January 2022
30 mg, 100 Count Bottle (NDC 68382-956-01) 07/12/2021 Availability and Estimated Shortage Duration (Discontinuance): January 2022

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English